Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An announcement from Guangzhou Baiyunshan Pharmaceutical Holdings Company ( (HK:0874) ) is now available.
Guangzhou Baiyunshan Pharmaceutical Holdings Company reported a decrease in both income from operations and net profit for the first quarter of 2025 compared to the same period in 2024. The company experienced a 2.06% decline in income from operations and a 6.99% decrease in net profit attributable to shareholders. Additionally, the net cash flow from operating activities saw a significant drop of 24.19%. Despite these declines, the total equity attributable to shareholders increased by 5.05%, indicating a stronger financial position.
More about Guangzhou Baiyunshan Pharmaceutical Holdings Company
Guangzhou Baiyunshan Pharmaceutical Holdings Company is a joint stock company with limited liability established in the People’s Republic of China. It operates in the pharmaceutical industry, focusing on the production and distribution of pharmaceutical products.
YTD Price Performance: 2.18%
Average Trading Volume: 30,548
Technical Sentiment Signal: Strong Buy
Current Market Cap: $5.46B
See more insights into 0874 stock on TipRanks’ Stock Analysis page.